The Filings Report

Morgan Stanley

MSNYSECIK 895421Financial / Capital Marketsfiscal year ends December73 quarters since 2008

Revenue, Q2 FY2026
$21.3B
+27.1% on Q2 FY2025
Net income
$5.6B
+57.7% on Q2 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$3.46
+62.4% on Q2 FY2025
Revenue, TTM
$78.0B
trailing four quarters
Net margin, TTM
25.8%
net income $20.2B
Free cash flow, TTM
—
Cash and equivalents
$160.1B
long-term debt $383.2B, Jun 30, 2026
Shares, 12-month change
−1.6%
1.57B shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$6.8B
2.3% of market value
Market value
$289.5B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 4, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Morgan Stanley reported revenue of $21.3B, +27.1% on Q2 FY2025, and net income of $5.6B (+57.7%). Diluted earnings per share were $3.46.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 4, 2026.

Revenue and net incomeRevenueNet income
$0$10B$20B$30BQ3'22, Revenue: $13.0BQ3'22, Net income: $2.6BQ3'22Q4'22, Revenue: $12.7BQ4'22, Net income: $2.2BQ4'22Q1'23, Revenue: $14.5BQ1'23, Net income: $3.0BQ1'23Q2'23, Revenue: $13.5BQ2'23, Net income: $2.2BQ2'23Q3'23, Revenue: $13.3BQ3'23, Net income: $2.4BQ3'23Q4'23, Revenue: $12.9BQ4'23, Net income: $1.5BQ4'23Q1'24, Revenue: $15.1BQ1'24, Net income: $3.4BQ1'24Q2'24, Revenue: $15.0BQ2'24, Net income: $3.1BQ2'24Q3'24, Revenue: $15.4BQ3'24, Net income: $3.2BQ3'24Q4'24, Revenue: $16.2BQ4'24, Net income: $3.7BQ4'24Q1'25, Revenue: $17.7BQ1'25, Net income: $4.3BQ1'25Q2'25, Revenue: $16.8BQ2'25, Net income: $3.5BQ2'25Q3'25, Revenue: $18.2BQ3'25, Net income: $4.6BQ3'25Q4'25, Revenue: $17.9BQ4'25, Net income: $4.4BQ4'25Q1'26, Revenue: $20.6BQ1'26, Net income: $5.6BQ1'26Q2'26, Revenue: $21.3BQ2'26, Net income: $5.6BQ2'26$0$10B$20B$30BQ3'22, Revenue: $13.0BQ3'22, Net income: $2.6BQ4'22, Revenue: $12.7BQ4'22, Net income: $2.2BQ4'22Q1'23, Revenue: $14.5BQ1'23, Net income: $3.0BQ2'23, Revenue: $13.5BQ2'23, Net income: $2.2BQ2'23Q3'23, Revenue: $13.3BQ3'23, Net income: $2.4BQ4'23, Revenue: $12.9BQ4'23, Net income: $1.5BQ4'23Q1'24, Revenue: $15.1BQ1'24, Net income: $3.4BQ2'24, Revenue: $15.0BQ2'24, Net income: $3.1BQ2'24Q3'24, Revenue: $15.4BQ3'24, Net income: $3.2BQ4'24, Revenue: $16.2BQ4'24, Net income: $3.7BQ4'24Q1'25, Revenue: $17.7BQ1'25, Net income: $4.3BQ2'25, Revenue: $16.8BQ2'25, Net income: $3.5BQ2'25Q3'25, Revenue: $18.2BQ3'25, Net income: $4.6BQ4'25, Revenue: $17.9BQ4'25, Net income: $4.4BQ4'25Q1'26, Revenue: $20.6BQ1'26, Net income: $5.6BQ2'26, Revenue: $21.3BQ2'26, Net income: $5.6BQ2'26

Net income losses drawn in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$100B$200B$300B$400BQ3'22, Cash and equivalents: $111.7BQ3'22, Long-term debt: $216.4BQ3'22Q4'22, Cash and equivalents: $128.1BQ4'22, Long-term debt: $233.9BQ4'22Q1'23, Cash and equivalents: $111.3BQ1'23, Long-term debt: $245.6BQ1'23Q2'23, Cash and equivalents: $105.0BQ2'23, Long-term debt: $243.8BQ2'23Q3'23, Cash and equivalents: $108.4BQ3'23, Long-term debt: $242.8BQ3'23Q4'23, Cash and equivalents: $89.2BQ4'23, Long-term debt: $260.5BQ4'23Q1'24, Cash and equivalents: $102.3BQ1'24, Long-term debt: $266.1BQ1'24Q2'24, Cash and equivalents: $90.2BQ2'24, Long-term debt: $269.9BQ2'24Q3'24, Cash and equivalents: $91.1BQ3'24, Long-term debt: $291.2BQ3'24Q4'24, Cash and equivalents: $105.4BQ4'24, Long-term debt: $284.3BQ4'24Q1'25, Cash and equivalents: $90.7BQ1'25, Long-term debt: $297.0BQ1'25Q2'25, Cash and equivalents: $109.1BQ2'25, Long-term debt: $320.1BQ2'25Q3'25, Cash and equivalents: $103.7BQ3'25, Long-term debt: $324.1BQ3'25Q4'25, Cash and equivalents: $111.7BQ4'25, Long-term debt: $341.7BQ4'25Q1'26, Cash and equivalents: $133.5BQ1'26, Long-term debt: $363.0BQ1'26Q2'26, Cash and equivalents: $160.1BQ2'26, Long-term debt: $383.2BQ2'26$0$100B$200B$300B$400BQ3'22, Cash and equivalents: $111.7BQ3'22, Long-term debt: $216.4BQ4'22, Cash and equivalents: $128.1BQ4'22, Long-term debt: $233.9BQ4'22Q1'23, Cash and equivalents: $111.3BQ1'23, Long-term debt: $245.6BQ2'23, Cash and equivalents: $105.0BQ2'23, Long-term debt: $243.8BQ2'23Q3'23, Cash and equivalents: $108.4BQ3'23, Long-term debt: $242.8BQ4'23, Cash and equivalents: $89.2BQ4'23, Long-term debt: $260.5BQ4'23Q1'24, Cash and equivalents: $102.3BQ1'24, Long-term debt: $266.1BQ2'24, Cash and equivalents: $90.2BQ2'24, Long-term debt: $269.9BQ2'24Q3'24, Cash and equivalents: $91.1BQ3'24, Long-term debt: $291.2BQ4'24, Cash and equivalents: $105.4BQ4'24, Long-term debt: $284.3BQ4'24Q1'25, Cash and equivalents: $90.7BQ1'25, Long-term debt: $297.0BQ2'25, Cash and equivalents: $109.1BQ2'25, Long-term debt: $320.1BQ2'25Q3'25, Cash and equivalents: $103.7BQ3'25, Long-term debt: $324.1BQ4'25, Cash and equivalents: $111.7BQ4'25, Long-term debt: $341.7BQ4'25Q1'26, Cash and equivalents: $133.5BQ1'26, Long-term debt: $363.0BQ2'26, Cash and equivalents: $160.1BQ2'26, Long-term debt: $383.2BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 4, 2026.

Morgan Stanley income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 3, 2025Q2 FY2025ended Jun 30, 2025filed Aug 4, 2025Q1 FY2025ended Mar 31, 2025filed May 5, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025Q3 FY2024ended Sep 30, 2024filed Nov 4, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue21,34820,58017,89018,22416,79217,73916,22315,383+27.1%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative—————————
Operating income—————————
Other income (expense)—————————
Pretax income7,3487,0115,7606,0284,6225,5444,9064,221+59.0%
Income tax1,6951,3731,3361,3731,0471,1731,182995+61.9%
Net income5,5815,5674,3974,6103,5394,3153,7143,188+57.7%
Diluted EPS ($)3.463.43—2.802.132.60—1.88+62.4%
Diluted shares (millions)1,5691,576—1,5901,5931,600—1,609—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 4, 2026.

Morgan Stanley balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 3, 2025Q2 FY2025ended Jun 30, 2025filed Aug 4, 2025Q1 FY2025ended Mar 31, 2025filed May 5, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025Q3 FY2024ended Sep 30, 2024filed Nov 4, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents160,135133,529111,695103,734109,13090,739105,38691,084+46.7%
Short-term investments—————————
Total current assets—————————
Total assets1,675,0571,581,4181,420,2701,364,8061,353,8701,300,2961,215,0711,258,027+23.7%
Total current liabilities—————————
Long-term debt383,156363,010341,681324,128320,128296,997284,307291,223+19.7%
Total liabilities1,557,6171,466,0341,307,6181,253,7551,244,6001,192,4491,109,6431,153,356+25.2%
Stockholders’ equity116,329114,286111,632109,962108,184106,812104,511103,647+7.5%
Shares outstanding (millions)1,5711,5771,5881,5891,5961,6041,6131,611—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 4, 2026.

Morgan Stanley cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 3, 2025Q2 FY2025ended Jun 30, 2025filed Aug 4, 2025Q1 FY2025ended Mar 31, 2025filed May 5, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025Q3 FY2024ended Sep 30, 2024filed Nov 4, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow(2,747)(7,098)(2,410)(3,332)11,829(23,976)11,800(17,323)−123.2%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization1,2027141,1381,3481,3078651,6451,270−8.0%
Share repurchases—————————
Dividends paid1,6771,7081,6881,7051,5841,6161,5851,590+5.9%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 19, 2026.

Income statement

Morgan Stanley income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 23, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Nov 30, 2008filed Aug 7, 2009FY2007ended Nov 30, 2007filed Feb 26, 2010
Revenue70,64561,76154,14353,66859,75548,75741,53840,10737,94534,63135,15534,27532,49326,17832,22731,23023,28022,14026,478
Cost of revenue———————————————————
Gross profit———————————————————
Research and development———————————————————
Selling, general and administrative———————————————————
Operating income———————————————————
Other income (expense)—————————————36(241)(307)———
Pretax income21,95417,59611,81314,08919,66814,41811,30111,23710,4038,8488,4953,5914,5585965966,1981,1301,2542,776
Income tax4,9294,0672,5832,9104,5483,2392,0642,3504,1682,7262,200(90)902(161)1,414743(297)16576
Net income16,86113,3909,08711,02915,03410,9969,0428,7486,1115,9796,1273,4672,932684,1104,7031,3461,7073,209
Diluted EPS ($)10.217.955.186.158.036.465.194.733.072.922.901.601.36(0.02)1.232.63(0.77)1.392.90
Diluted shares (millions)1,5921,6111,6461,7131,8141,6241,6401,7381,8211,8871,9531,9711,9571,9191,6751,4111,1851,0731,025

Balance sheet

Morgan Stanley balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 23, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Nov 30, 2008filed Aug 7, 2009FY2007ended Nov 30, 2007filed Feb 26, 2010
Cash and equivalents111,695105,38689,232128,127127,725105,65482,17187,19680,39577,36085,55287,59159,88346,90447,31247,61531,99178,67024,659
Short-term investments———————————————————
Total current assets———————————————————
Total assets1,420,2701,215,0711,193,6931,180,2311,188,1401,115,862895,429853,531851,733814,949787,465801,510832,702780,960749,898807,698771,462676,764—
Total current liabilities———————————————————
Long-term debt341,681284,307260,544233,867227,363213,388190,060188,117191,063164,775153,768152,772153,575169,571184,234192,457193,374179,835—
Total liabilities1,307,6181,109,6431,093,7111,079,0001,081,5421,012,713812,732772,125773,267737,772711,281729,406763,672711,223679,820742,291718,682627,308—
Stockholders’ equity111,632104,51199,038100,141105,441101,78181,54980,24677,39176,05075,18270,90065,92162,10962,04957,21146,68848,753—
Shares outstanding (millions)1,5881,6131,6351,6821,7811,8141,5991,7091,7921,8661,9591,9771,9761,9611,9791,5461,398——

Cash flow statement

Morgan Stanley cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 26, 2021FY2019ended Dec 31, 2019filed Feb 27, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 27, 2018FY2016ended Dec 31, 2016filed Feb 27, 2017FY2015ended Dec 31, 2015filed Feb 23, 2016FY2014ended Dec 31, 2014filed Mar 2, 2015FY2013ended Dec 31, 2013filed Feb 25, 2014FY2012ended Dec 31, 2012filed Feb 26, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Feb 26, 2010FY2008ended Nov 30, 2008filed Aug 7, 2009FY2007ended Nov 30, 2007filed Feb 26, 2010
Operating cash flow(17,889)1,362(33,536)(6,397)33,971(25,231)40,7737,305(4,505)5,383(4,463)——24,54815,89240,614(45,951)73,417(22,249)
Capital expenditures———————————————————
Free cash flow (CFO − capex)———————————————————
Depreciation and amortization4,6585,1614,2563,9984,2163,7692,6431,8441,7531,7361,4331,1611,5111,5811,4041,4191,224794475
Share repurchases————————————691227317317501,117438
Dividends paid6,5936,1385,7635,4014,1712,7392,6272,3752,0851,7461,4559044754698341,1561,7321,2271,219

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$52M
33 sales by 8 insiders; officers and directors $52M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 22, 2026Mitsubishi Ufj Financial Group INC10% ownerdisposition to issuer1M$212.57$285M375MSep 24, 2026
Sep 15, 2026Morgan Stanley—otherindirect94——0Sep 17, 2026
Jul 30, 2026Mitsubishi Ufj Financial Group INC10% ownerdisposition to issuer414,396$213.28$88M377MAug 3, 2026
Jul 28, 2026Schapiro Mary LDirectoropen-market sale1,000$212.06$212K40,843Jul 29, 2026
Jul 28, 2026Schapiro Mary LDirectorgift2,325$0.00—38,518Jul 29, 2026
Jul 17, 2026Pizzi Michael A.Head Technology & Operationsopen-market sale17,064$215.00$4M128,871Jul 17, 2026
Jul 17, 2026Pizzi Michael A.Head Technology & Operationsopen-market sale7,101$216.88$2M121,770Jul 17, 2026
Jul 16, 2026Yeshaya SharonChief Financial Officeropen-market sale6,382$222.51$1M136,810Jul 17, 2026
Jul 16, 2026Yeshaya SharonChief Financial Officeropen-market saleindirect9,172$222.51$2M0Jul 17, 2026
Jun 1, 2026Nally Dennis MDirectoraward1,310$0.00—46,731Jun 2, 2026
Jun 1, 2026Nally Dennis MDirectoraward345$209.96$73K47,076Jun 2, 2026
Jun 1, 2026Wilkins Rayford JRDirectoraward1,310$0.00—78,269Jun 2, 2026
Jun 1, 2026Butler MeganDirectoraward1,310$0.00—6,019Jun 2, 2026
Jun 1, 2026Butler MeganDirectortax withholding190$209.96$40K5,829Jun 2, 2026
Jun 1, 2026James Erika HDirectoraward1,310$0.00—13,253Jun 2, 2026
Jun 1, 2026Good Lynn JDirectoraward1,310$0.00—3,227Jun 2, 2026
Jun 1, 2026Good Lynn JDirectoraward274$209.96$58K3,501Jun 2, 2026
Jun 1, 2026Traquina Perry MDirectoraward1,310$0.00—90,963Jun 2, 2026
Jun 1, 2026Traquina Perry MDirectoraward369$209.96$78K91,332Jun 2, 2026
Jun 1, 2026Peterson Douglas L.Directoraward1,310$0.00—11,398Jun 2, 2026
Jun 1, 2026Peterson Douglas L.Directoraward274$209.96$58K11,672Jun 2, 2026
Jun 1, 2026Miscik Judith ADirectoraward1,310$0.00—66,494Jun 2, 2026
Jun 1, 2026Herz Robert HDirectoraward1,310$0.00—102,563Jun 2, 2026
Jun 1, 2026Leibowitz Shelley BDirectoraward1,310$0.00—48,370Jun 2, 2026
Jun 1, 2026Glocer Thomas HDirectoraward1,310$0.00—124,038Jun 2, 2026

Full insider history for Morgan Stanley, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held MS in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MS by quarter.

FundManagerQuarterValueSharesWeightMove
Baron Capital GroupRon BaronQ2 2026$2M9,6200.00%added +5.7%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
MORGAN STANLEY, CIK 895421 on EDGAR
Extract generated
August 27, 2026
Withheld
2 line-years whose four quarters do not sum to the filed year: pretax income FY2009, pretax income FY2011
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues, RevenuesNetOfInterestExpense
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: not filed
Operating income: not filed
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: not filed
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/MS.json